[
    [
        {
            "time": "",
            "original_text": "北上资金白酒新能源都要，「微信、支付宝收款码禁用」被误读？",
            "features": {
                "keywords": [
                    "北上资金",
                    "白酒",
                    "新能源",
                    "微信",
                    "支付宝",
                    "收款码",
                    "误读"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "消费",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "北上资金白酒新能源都要，「微信、支付宝收款码禁用」被误读？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "填补未被满足的临床需求，泰格医药助力全球首款皮下注射PD-L1抑制剂恩沃利单抗获批",
            "features": {
                "keywords": [
                    "泰格医药",
                    "临床需求",
                    "PD-L1抑制剂",
                    "恩沃利单抗",
                    "获批"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "填补未被满足的临床需求，泰格医药助力全球首款皮下注射PD-L1抑制剂恩沃利单抗获批",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]